Search





Search





Markets
/
Stocks
/
fhtx
/

Foghorn Therapeutics Inc.

FHTX

Add to Watchlist

4.525USD

-0.215-4.54%

Close 07-31 16:00（ET）Quotes delayed by 15 min

265.66MMarket Cap

LossP/E TTM

Foghorn Therapeutics Inc.

4.525

-0.215-4.54%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-31

Previous score

7.00

Change

The current institutional shareholding score of Foghorn Therapeutics Inc. is 7.00, ranking 80 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 72.78%, representing a quarter-over-quarter decrease of 2.53%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.69% of shares outstanding, with 0.32% decrease in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

Flagship Ventures

12.67M

Fidelity Management & Research Company LLC

5.40M

-1.43%

BVF Partners L.P.

5.30M

Eli Lilly and Company

4.00M

Deerfield Management Company, L.P.

3.65M

+12.09%

Kadoch (Cigall)

3.65M

+0.79%

Raymond James & Associates, Inc.

2.51M

+1.76%

The Klarman Family Foundation

2.14M

BlackRock Institutional Trust Company, N.A.

2.13M

+3.29%

Euclidean Capital, L.L.C.

1.57M